Japan’s Eisai saw its US listed shares rise 56% – up by more than Biogen’s 38% jump after US regulators...

With unprecedented spikes in Covid infection rates and states reporting extreme shortages of vaccines, India banned the export of anti-viral drug Remdesivir and its ingredients on Sunday

(ATF) China’s vaccination campaign has taken a double body blow in recent days, with a leading scientist criticising...

(ATF) With vaccine diplomacy emerging as the centrepiece of the global foreign policy...

Serum Institute of India rejects claims of side-effects, says trial participant's lawsuit is 'malicious' and 'misconceived'

(ATF) Chinese vaccine stocks have plunged for two days straight this...

(ATF) High-yield corporate bonds joined a global stock rally after Pfizer said its Covid-19 vaccine had...

US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study after calls for greater transparency. 

Experts raised concerns about the Wuhan lab during an accreditation process - concerns that were amplified after the Covid-19 pandemic spread from the same city